{"name":"Neurotrope Bioscience, Inc.","slug":"neurotrope-bioscience-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":299061,"revenueGrowth":0,"grossMargin":0,"rdSpend":322225,"netIncome":-28737448,"cash":5497671,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Bryostatin","genericName":"Bryostatin","slug":"bryostatin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Bryostatin","genericName":"Bryostatin","slug":"bryostatin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"date":"2026-03-31","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2025-12-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-11-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxPeUx4N1VxLVVxc28zWUFqN2xxa0gwU2xfY2FldkpYcDBDNmFxR2V0azFwVXhGN0dNZFJTd3ZXVzU4cHYtbzZHUmNxVUhKandmdlhuOXM1UHRPbTV6VUs0NEt3WnlSYkZib2JaYTcwM1dOTmlSRzJId0E4bXF1M1FCcmJ6QzFQQ0VtZFVkWGN5aGM0X0FmY1RtQWEzZlNqWWtFQ0pmUHZvNU9SV3Q5LUdiekNaZmo0U2xZNkROM2lMQ05MM1REWkMtLUlYVDg3a29idE4zU3NPekFLRHJUeTZNRzhSSFkzQUhfV0VVbWRTcEtFclpHcUxVYXdXT2JINkhubFBNSzlJSldFMHEyLTliclQwTGpyVlNEWG5XRzdR?oc=5","date":"2025-08-12","type":"trial","source":"GlobeNewswire","summary":"Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ - GlobeNewswire","headline":"Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNdWVjYzh3NXhjUkFPaFJQT2hmQ25DbVZ5TDFvUV8wOUh6aFhvWEhrMGhmbXQ1T1BUNW9RZHY4bXZJV2FOSkZwNVRiZFJaZ1JEWmFMNUFhb1d1c1dGYUktSzJIUUdPQlJFd19GTk5DRkpMT0dxNndHN3lIQmJ1eG8tRmZXWjRMLWJuSjdia1J6eEQ3YWx1Y0VHTmVB?oc=5","date":"2020-12-14","type":"pipeline","source":"NeuroNews International","summary":"Neurotrope completes formation of new company Synaptogenix - NeuroNews International","headline":"Neurotrope completes formation of new company Synaptogenix","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAJBVV95cUxOZVBBSGtqZW9UVWRENTFnVF9BWlphelZBRjBQMnFBM2tkRzVWaXo0Z3Atbld3VXl6RWpuVHBXQ19VY3Z4ejBObURZUDlpQ2xndTR3cnhLUDZOdjVkcWdiUW9qd193Sm40bS1nQlZUYmdMeE9IQUhwVmNDTHVSQXQ1ZzV0dUFLQVhwSTdhQWVmQ0UxVmN4RzcxcWZJdGdSWm5UOHFDOVNYWU1oRmR5QUZCRVlEM2o4TXI0azV1YVV2ZFRfT3c2UjRObWhjc01iT0xzcjZ0dXFJQ1QtZkJPd1hzZy1SQ0VUTVRoUXdXdjN0WW4wcU9hV28xY0tpY0gzSVpYYmQ1bg?oc=5","date":"2020-05-18","type":"deal","source":"PR Newswire","summary":"Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company - PR Newswire","headline":"Neurotrope and Metuchen Pharmaceuticals Announce Merger Agreement to Form Petros Pharmaceuticals, a Men's Health Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE10WmZFS05QMF95SzZNTlVvdlRmcFRaT0xFME1RbjVJVjAwdlBkLWpLYjZqOWtENzJoOWZaMjBVSEdiOVowSzR3TlpoWHlKRWNOY1VqQlQ5YXVudlZPWkVqUjYyM3NFbjhMekxJOEdzZ0liQXNvbV9HZGVaWDlpaXM?oc=5","date":"2016-12-12","type":"pipeline","source":"BioPharma Dive","summary":"Women in biotech: Out on the frontline - BioPharma Dive","headline":"Women in biotech: Out on the frontline","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":299061,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":299061,"period":"2025-12-31"},{"value":0,"period":"2024-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":322225,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-28737448,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":5497671,"cashHistory":[],"totalAssets":25835021,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}